π€ La Machine #66: Scale or Sell? Gleamer's β¬230M Question
Summary
Gleamer, a Paris-based AI radiology platform, has been acquired by U.S. imaging giant RadNet for β¬230 million. Founded in 2017, Gleamer had secured approximately β¬50 million across three funding rounds, including β¬27 million in 2023. By late 2025, the company achieved around β¬30 million in annual recurring revenue and served about 700 clients across 44 countries. This acquisition, which integrates Gleamer into RadNet's DeepHealth unit, follows Gleamer's own consolidation efforts in 2025 through the acquisitions of Pixyl and Caerus Medical, both specializing in AI-powered medical MRI readings. The deal represents a significant exit for the French tech ecosystem.
Key takeaway
For entrepreneurs in European AI startups considering growth strategies, Gleamer's β¬230 million acquisition by RadNet illustrates a clear path to liquidity through strategic sale. Your focus on strong commercial traction and international expansion can position your company as an attractive target for larger, established players, even if it means foregoing the "champion" title. Evaluate whether scaling independently or joining a larger entity aligns best with your long-term vision and market opportunities.
Key insights
AI radiology startup Gleamer was acquired by RadNet for β¬230M, highlighting a trend of European AI exits to larger U.S. players.
Principles
- Commercial traction attracts strategic buyers.
- Consolidation can precede acquisition.
In practice
- Target β¬30M ARR for significant acquisition interest.
- Expand globally to 40+ countries for market reach.
Topics
- AI Radiology
- Sovereign AI
- AI Job Market
- Generative AI
Best for: Entrepreneur, Investor, AI Product Manager, AI Engineer
Related on AIssential
Editorial summary, takeaway, and curation by AIssential. Original article published by The French Tech Journal.